De-Iron: a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent myelodysplastic syndromes.

Killick, Sally; Jackson, Aimee; Coulthard, Helen C; Yap, Christina; Das-Gupta, Emma; Pennell, Dudley J; Porter, John; Bowen, David; Culligan, Dominic

Killick, Sally; Jackson, Aimee; Coulthard, Helen C; Yap, Christina; Das-Gupta, Emma; Pennell, Dudley J; Porter, John; Bowen, David; Culligan, Dominic.

Affiliation

Killick S; Royal Bournemouth and Christchurch NHS Foundation Trust, Bournemouth, UK.
Jackson A; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK.
Coulthard HC; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK.
Yap C; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK.
Das-Gupta E; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
Pennell DJ; Nottingham University Hospitals NHS Trust, Nottingham, UK.
Porter J; Cardiovascular Magnetic Resonance (CMR) Unit, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Bowen D; Research Department of Haematology, University College London, London, UK.
Culligan D; St James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Br J Haematol ; 189(6): e237-e240, 2020 06.

Article in En | MEDLINE | ID: mdl-32342485

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Transfusion / Myelodysplastic Syndromes / Deferasirox Type of study: Clinical_trials / Observational_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2020 Document type: Article Affiliation country: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google